Skip to main content

Table 2 Effect of catheter amangement in different groups

From: Management of enterococcal central line-associated bloodstream infections in patients with cancer

1) CLABSI with MBI
Outcome Catheter removal a,b p-value Pairwise comparisons with significant differences
<  3 Days 3–7 Days >  7 Days c   
(n = 23) (n = 27) (n = 60)   
N (%) N (%) N (%)   
Final outcome d, e     0.004 “3–7 days” vs “>  7 days”: P = .003
 Success 18 (78) 18 (67) 56 (93)   
 Failure 5 (22) 9 (33) 4 (7)   
2) CRBSI or CLABSI without MBI
Outcome Catheter removal a, b p-value Pairwise comparisons with significant differences
<  3 Days 3–7 Days >  7 Days c   
(n = 24) (n = 19) (n = 37)   
N (%) N (%) N (%)   
Final outcome d, e     0.025 None (due to alpha adjustment for multiple comparisons)
 Success 21 (88) 12 (63) 34 (92)   
 Failure 3 (13) 7 (37) 3 (8)   
3) Non-CLABSI
Outcome Catheter removal a, b p-value Pairwise comparisons with significant differences
<  3 Days 3–7 Days >  7 Days c   
(n = 22) (n = 19) (n = 88)   
N (%) N (%) N (%)   
Final outcome d, e     0.006 “<  3 days” vs “>  7 days”: P = .006
 Success 14 (64) 14 (74) 79 (90)   
 Failure 8 (36) 5 (26) 9 (10)   
  1. Abbreviations: CLABSI central line-associated bloodstream infection, MBI mucosal barrier injury
  2. a Since positve blood culture
  3. b Patients with lock therapy were excluded from the analysis
  4. c Included patietns with catheter retained
  5. d This is a composite outcome. Success means that a patient had no infection-related complication and no infection-related death within 3 months after bacteremia, as well as no infection-related recurrence within 3 months after microbiological resolution
  6. e Patients who had no microbiological resoltuion, or who had missing data for infecton-related complication, or infection-related death, or recurrence, or who died within 7 days after bacteremia were excluded from the analysis